drugset / Trial / NCT01101932
Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
RandomizedSingle-groupDouble-blindBasic science
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics (how the drug effects certain target sites of activity in the body) of escalating doses of oral PF-04308515 in healthy volunteers for 14 days as well as one oral dose of a tablet formulation administered for 1 day.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04308515 | Unknown | 3 mg | Oral |
| Subject | PF-04308515 | Unknown | 10 mg | Oral |
| Subject | PF-04308515 | Unknown | 20 mg | Oral |
| Subject | PF-04308515 | Unknown | 30 mg | Oral |
| Subject | PF-04308515 | Unknown | 100 mg | Oral |
Indications
No indication recorded.